Barr’s Generic Premarin ANDA To Be Filed By June; Cenestin Sales Growing

Barr Laboratories plans to submit an ANDA for generic Premarin (conjugated estrogens) by June without waiting for a decision in Wyeth's suit against Barr's ingredient supplier